Peter Muraki
Physician · Permanente Medical Group Inc
Credentials: · ·
History
- 2025–Present
Permanente Medical Group Inc
- 2014–2018
Research
Papillary renal cell carcinoma: Review
Review · Seminars in Urologic Oncology · 2021 · 74 citations
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL
Journal of Kidney Cancer and VHL · 2022 · 5 citations
Cancer Medicine · 2023 · 2 citations
4 papers
- AA
2 papers · 1 as a resident
2 papers
2 papers · 2 as a resident
1 paper
1 paper
1 paper
- GB
1 paper
